Total item
Cart Subtotal
$0.00 Biological Activity
TAK-875 is a potent, selective, and orally bioavailable GPR40 agonist.
| In vitro (25°C) | DMSO | 100 mg/mL (187.39 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| In vivo | 0.5% CMC/0.25% Tween 80 | 30 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 18.74 mL | 93.7 mL | 187.41 mL |
| 0.5 mM | 3.75 mL | 18.74 mL | 37.48 mL |
| 1 mM | 1.87 mL | 9.37 mL | 18.74 mL |
| 5 mM | 0.37 mL | 1.87 mL | 3.75 mL |
*The above data is based on the productmolecular weight 533.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11018 |
|---|---|
| Actions | Agonist |
| M. Wt | 533.6 |
| Formula | C29H32O7S.1/2H2O |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1000413-72-8 |
| Synonyms | TAK875 |
| SMILES | CC1=CC(=CC(=C1C2=CC(=CC=C2)COC3=CC4=C(C=C3)[[email protected]@H](CO4)CC(=O)O)C)OCCCS(=O)(=O)C |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy TAK-875 (Fasiglifam) | TAK-875 (Fasiglifam) Supplier | purchase TAK-875 (Fasiglifam) | TAK-875 (Fasiglifam) cost | TAK-875 (Fasiglifam) manufacturer | order TAK-875 (Fasiglifam) | TAK-875 (Fasiglifam) distributor | buy 1000413-72-8 | 1000413-72-8 Supplier | purchase 1000413-72-8 | 1000413-72-8 cost | 1000413-72-8 manufacturer | order 1000413-72-8 | 1000413-72-8 distributor
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: [email protected]
Not your Region? View all Distributors
Adooq Quality Guarantee
We promise all products perform as described.